KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Accumulated Expenses (2016 - 2019)

Bristol Myers Squibb has reported Accumulated Expenses over the past 11 years, most recently at $5.9 billion for Q1 2019.

  • Quarterly Accumulated Expenses rose 5.3% to $5.9 billion in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $5.9 billion through Mar 2019, up 5.3% year-over-year, with the annual reading at $6.5 billion for FY2018, 7.9% up from the prior year.
  • Accumulated Expenses was $5.9 billion for Q1 2019 at Bristol Myers Squibb, down from $6.5 billion in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $6.5 billion in Q4 2018 and troughed at $1.8 billion in Q1 2015.
  • The 5-year median for Accumulated Expenses is $5.1 billion (2017), against an average of $4.8 billion.
  • Year-over-year, Accumulated Expenses fell 10.32% in 2015 and then surged 140.7% in 2016.
  • A 5-year view of Accumulated Expenses shows it stood at $4.7 billion in 2015, then rose by 11.25% to $5.3 billion in 2016, then rose by 14.1% to $6.0 billion in 2017, then grew by 7.9% to $6.5 billion in 2018, then fell by 9.75% to $5.9 billion in 2019.
  • Per Business Quant, the three most recent readings for BMY's Accumulated Expenses are $5.9 billion (Q1 2019), $6.5 billion (Q4 2018), and $5.9 billion (Q3 2018).